Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Insufficient chart data. Estimates will improve as the show charts.
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 ~2x weekly·119 episodes·Last published 2d ago - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Not detected.
Recent guests
Recent episodes
Genomic Determinants and Biomarkers: Defining Leukemias
Jun 24, 2026
Personalized Deintensification Therapy For HPV-Positive Head And Neck Cancers
Jun 15, 2026
Low-Dose Radiation Therapy Emerges as a Viable Alternative for Refractory Osteoarthritis
Jun 15, 2026
Advancing Meningioma Care: Precision Imaging and Targeted Therapies with DOTATATE PET, Lutathera, and GammaTile
Jun 8, 2026
Advancing Meningioma Care: A Multidisciplinary Approach at Penn Medicine
May 15, 2026
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/24/26 | Genomic Determinants and Biomarkers: Defining Leukemias | Leukemia specialist Matthew Connor addresses parsing the genomic determinants of the leukemias for diagnosis, and reviews the mystery of mixed phenotype acute leukemia, a rare type of acute leukemia that expresses phenotypic markers of both AML and ALL. Learn more about Matthew Connor, MD | — | ||||||
| 6/15/26 | Personalized Deintensification Therapy For HPV-Positive Head And Neck Cancers | Head and neck reconstructive surgeon Karthik Rajasekaran, MD, and radiation oncologist Michelle Gentile, MD, discuss the nuances and benefits of deintensification, a personalized approach to care for individuals with HPV-positive head and neck cancers that aims to maintain high cure rates while reducing long-term toxicities. (Part 1 of 2) | — | ||||||
| 6/15/26 | Low-Dose Radiation Therapy Emerges as a Viable Alternative for Refractory Osteoarthritis | Dr. John Plastaras offers the insight of a clinician researcher to an engaging discussion of the emergence and application of low-dose radiation therapy as a non-invasive, non-pharmacologic alternative for chronic and refractory osteoarthritis in individuals seeking relief from chronic joint pain when other treatments fail. Learn more about Logan Barnes, PA-C Learn more about John Plastaras, MD, PhD | — | ||||||
| 6/8/26 | Advancing Meningioma Care: Precision Imaging and Targeted Therapies with DOTATATE PET, Lutathera, and GammaTile✨ | meningioma treatmentprecision imaging+3 | Christina Jackson, MDEmily Lebow, MD | DOTATATE PETLutathera+2 | — | meningiomaDOTATATE PET+5 | — | — | |
| 5/15/26 | Advancing Meningioma Care: A Multidisciplinary Approach at Penn Medicine✨ | meningiomaneurosurgery+3 | Christina Jackson, MDEmily Lebow, MD | Penn Medicine | — | meningiomasurgery+3 | — | — | |
| 4/15/26 | Melanoma - a Model Disease for Scientific Innovation✨ | melanomacancer treatment+4 | Ravi K. Amaravadi, MD | Stage IV metastatic melanomaFDA-approved therapies+5 | — | melanomacancer therapies+5 | — | — | |
| 4/1/26 | Proton Therapy As De-Intensification Strategy For HPV+ Head and Neck Cancers✨ | proton therapyHPV+ head and neck cancers+3 | Alexander Lin, MD | Penn MedicineIMRT | HPV+oropharyngeal cancer | proton therapyHPV++5 | — | — | |
| 3/13/26 | Muscle-Sparing Direct Anterior Approach To Total Hip Arthroplasty✨ | orthopaedicship surgery+3 | Dr. Kimberly Stevenson | Penn Medicinemuscle-sparing direct anterior approach+1 | — | muscle-sparingdirect anterior approach+3 | — | — | |
| 3/13/26 | T Cell Lymphomas—Navigating The Journey From Diagnosis To Treatment And Beyond✨ | T cell lymphomasdiagnosis+3 | Colin Thomas, MDJina Chung, MD | Penn MedicineAbramson Cancer Center | — | T cell lymphomasdiagnosis+3 | — | — | |
| 2/26/26 | Gynecologic oncology: the known, the unknown, and the promising✨ | gynecologic oncologyHPV vaccine+4 | Noah Goldman, MD | HPV vaccinePenn Medicine Princeton Health | — | gynecologic oncologyHPV vaccine+4 | — | — | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 2/4/26 | The Center for Precision Surgery Marks 10 Years of Illuminating Cancer Cells in Practice and Research✨ | precision surgerycancer cells+4 | Sunil SinghalJanos Tanyi+1 | Cytalux®Penn Center for Precision Surgery | — | precision surgerycancer+4 | — | — | |
| 2/3/26 | Sickle Cell Anemia at Penn Medicine: What's New and What's Next✨ | sickle cell diseasetreatment advances+4 | Nadia Dawn AliScott Peslak | Penn MedicineSickle Cell Anemia | — | sickle cell anemiatreatment+4 | — | — | |
| 1/26/26 | The Vessel is in the Details: Management of Acute and Chronic Dissection of the Aorta✨ | aortic dissectioncardiac surgery+3 | Melanie Freas, DNP, CRNPKatelyn Rosemann, MSN, CRNP | Penn Medicine | — | aortic dissectionmanagement+5 | — | — | |
| 1/8/26 | Biomarker Testing as a Determinant of Treatment in Non-Small Cell Lung Cancer | Dr. Melina Marmarelis offers an overview of biomarker testing—and particularly liquid biopsy—as a fulcrum of precision medicine at Penn Medicine in the determination of tailored treatments for patients with metastatic non-small cell lung cancer. | — | ||||||
| 12/15/25 | Transorbital Approach: Syncing Neurosurgery, Oculoplastics, and ENT, for Skull Base Tumor Resection | Surgeons Christina Jackson, César Briceño, and Jennifer Douglas of Penn Neurosurgery, Oculoplastics, and ENT discuss their combined roles in the transorbital approach (TOA) to tumors of the skull base. The TOA reaches meningiomas and other deep-seated tumors through the orbit of the eye to avoid craniotomy and its after-effects. | — | ||||||
| 11/11/25 | Now leading the ABOS, Charles Nelson, MD, of Penn Orthopaedics, has mentorship, AI, in sight. | Penn Orthopaedics surgeon Charles Nelson, MD, reflects on his role as recently elected President of the American Board of Orthopaedic Surgery, as well as the organization’s history, its role in the development of orthopaedic surgeons, and the looming challenges of AI. Learn more about Charles L. Nelson, MD | — | ||||||
| 9/24/25 | Bariatric Surgery and Obesity Medicine | Lisa Dobruskin., MD, reviews the management of obesity at Penn Princeton Bariatrics with a focus on continuity of patient-oriented care and the pathophysiology of weight gain and loss. Dr. Dobruskin reviews current minimally invasive surgical offerings, offers guidance on weight-loss medications, and discusses the timing of intervention and other concerns for those considering bariatric surgery. | — | ||||||
| 9/24/25 | Discussion on Treatment of Abdominal Wall Hernias, Including Ventral Hernias and Inguinal Hernias | Abdominal wall hernias appear at points of congenital or acquired weakness in the abdominal muscle wall, and their correction involves an understanding of both the nature of the precipitating flaw and the character of the abdominal wall. In this podcast, Lancaster-based surgeon Kelly Janke, DO, discusses these elements in the context of advanced hernia surgery. and reviews the factors that predispose individuals to either good or less-than-optimal outcomes following intervention. | — | ||||||
| 9/4/25 | Bicuspid Aortic Valve Surveillance at Penn Medicine | For more than two decades, advanced practice providers at the Penn Surveillance Clinic have monitored and counseled patients with bicuspid aortic valve (BAV) disease. A congenital disorder, BAV is associated with the connective tissue syndromes and in these and other affected populations is a leading cause of irreversible aortic root dilation, aneurysm, rupture, and dissection. Affiliated with the Center for Bicuspid Aortic Valve Diseases at Penn Medicine, the APP-led Surveillance Clinic follows patients as they progress from dilation to aneurysm to monitor the size of their aortic diameter via imaging, adjust treatment plans, and, when needed, prepare patients for surgery and recovery. | — | ||||||
| 8/29/25 | Penn Pregnancy Early Access Center (PEACE) | Obstetrician-gynecologist Dr. Sarita Sonalkar provides an insightful review of the Penn Pregnancy Early Access Center, or PEACE Program, an integrated family planning and urgent pregnancy care center. In her engaging discussion, Dr. Sonalkar highlights the various benefits and services of the Program, including shared decision-making, timely appointments, contraception, counseling, ultrasound and surgical services, and much more. | — | ||||||
| 8/6/25 | Preventing a Silent Killer: Aortic Aneurysms Detection and Management | Aortic aneurysms contribute to thousands of aortic dissections and ruptures every year in the United States, and are virtually undetectable in the general population. In this podcast, cardiac surgeon Jeremy McGarvey, MD, describes the effort to detect aortic aneurysms and their multidisciplinary management at PennMedicine. Learn more about Jeremy McGarvey, MD | — | ||||||
| 8/4/25 | The heart in 16/16 time: treating ventricular tachycardia | Drs Timothy Markman and Keith Cengel review the devices, medications and surgical approaches to ventricular tachycardia (VT), an arrhythmia linked to sudden death, our current understanding of the origins of VT, and clinical research into new approaches at Penn, including RADIATE VT, which compares radioablation to radiofrequency for VT ablation. | — | ||||||
| 6/23/25 | Unnerving Resistant Hypertension: Renal Denervation | Is there a surgical answer to intractable hypertension? Drs. Taisei Kobayashi and Debra Cohen offer their clinical insights (surgery and nephrology, respectively) on catheter-based renal denervation and its indications for patients with refractory hypertension, as well as supporting evidence for efficacy and precautions for eligibility. | — | ||||||
| 6/16/25 | Navigating Multiple Myeloma - A Roadmap For Long-Term Care | The second most common hematologic malignancy, multiple myeloma has an incidence of ~35,000 new cases a year in the United States. In this episode, Drs. Adam Cohen and Shivani Kapur convene to lay out a roadmap for the treatment journey for patients with the disease, from early treatment options, particularly autologous transplant, to recent advances in immunotherapy, combination maintenance therapies, and clinical trials. | — | ||||||
| 6/13/25 | Penn Medicine Princeton | Multidisciplinary approach to non-small cell and small cell lung cancer | Dr. Leonid Emerel reviews the management of non-small cell and small cell lung cancer at the multidisciplinary cancer clinic in the Medical Arts Pavilion at Penn Medicine Princeton Thoracic Surgery. Dr Emeril reviews diagnostics, chemotherapy, immunotherapy and surgery, and the value of rapid access to the surgeons on staff. | — | ||||||
Showing 25 of 123
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.